Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowSales of Johnson & Johnson's medical devices and diagnostics by franchise 2020-2022
Johnson & Johnson’s medical devices and diagnostics segment earned about 9.7 billion U.S. dollars through its surgery franchise specifically, in 2022. Orthopedics was the second-largest franchise, generating roughly 8.6 billion U.S. dollars that year.
In 2022, some 27.4 billion U.S. dollars were generated through the medical devices and diagnostics division. Roughly 16 percent of the company’s global revenue was generated through consumer health. Over the years, the multinational company with its various segments generated more than half of its revenues in the United States, making it the company’s main market. In 2022, roughly 23.4 billion U.S. dollars were generated in Europe, the company’s second most yielding region.
J&J’s revenue
In 2022, Johnson & Johnson’s global revenue amounted to some 95 billion U.S. dollars, which was an increase of around one billion U.S. dollars compared to the previous year. J&J has three major divisions: pharmaceutical, medical devices and diagnostics, and consumer.In 2022, some 27.4 billion U.S. dollars were generated through the medical devices and diagnostics division. Roughly 16 percent of the company’s global revenue was generated through consumer health. Over the years, the multinational company with its various segments generated more than half of its revenues in the United States, making it the company’s main market. In 2022, roughly 23.4 billion U.S. dollars were generated in Europe, the company’s second most yielding region.
